Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
November 1, 1979
Naphthoxylactic acid after single and long-term doses of propranolol
T Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1987
Antihypertensive effects of parenteral nicardipine alone and in combination with captopril
K A Conrad, T C Fagan, P Mayshar, et al.
The American Journal of Cardiology
|
September 15, 1986
Postprandial alterations in hemodynamics and blood pressure in normal subjects
T C Fagan, P R Sawyer, L A Gourley, et al.
Journal of Clinical Pharmacology
|
January 1, 1995
Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil
P J Davis, T C Fagan, M J Topmiller, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 1, 1988
Single versus triplicate measurements of blood pressure and heart rate
T C Fagan, K A Conrad, P V Mayshar, et al.
British Journal of Clinical Pharmacology
|
April 1, 1982
Early kinetics of intravenous propranolol
T C Fagan, T Walle, U K Walle, et al.
Pharmacotherapy
|
May 1, 1986
Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetes
T C Fagan, E B Nelson, K C Lasseter, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1987
Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet
T C Fagan, T Walle, M J Oexmann, et al.
Journal of Clinical Hypertension
|
March 1, 1986
Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance
T C Fagan, L A Gourley, P R Sawyer, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1981
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites
T Walle, T C Fagan, U K Walle, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
November 1, 1979
Naphthoxylactic acid after single and long-term doses of propranolol
T Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1987
Antihypertensive effects of parenteral nicardipine alone and in combination with captopril
K A Conrad, T C Fagan, P Mayshar, et al.
The American Journal of Cardiology
|
September 15, 1986
Postprandial alterations in hemodynamics and blood pressure in normal subjects
T C Fagan, P R Sawyer, L A Gourley, et al.
Journal of Clinical Pharmacology
|
January 1, 1995
Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil
P J Davis, T C Fagan, M J Topmiller, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 1, 1988
Single versus triplicate measurements of blood pressure and heart rate
T C Fagan, K A Conrad, P V Mayshar, et al.
British Journal of Clinical Pharmacology
|
April 1, 1982
Early kinetics of intravenous propranolol
T C Fagan, T Walle, U K Walle, et al.
Pharmacotherapy
|
May 1, 1986
Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetes
T C Fagan, E B Nelson, K C Lasseter, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1987
Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet
T C Fagan, T Walle, M J Oexmann, et al.
Journal of Clinical Hypertension
|
March 1, 1986
Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance
T C Fagan, L A Gourley, P R Sawyer, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1981
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites
T Walle, T C Fagan, U K Walle, et al.
Page
of 5